Effect of therapy on the serum level of alpha-1 fetoprotein in embryonal cell carcinoma.
D000510:Alpha-Globulins / Q000032:analysis*; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D005326:Fetal Proteins / Q000032:analysis*; D006801:Humans; D005779:Immunodiffusion; D007122:Immunoelectrophoresis; D008207:Lymphatic Metastasis; D008297:Male; D008466:Mechlorethamine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D013724:Teratoma / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D013736:Testicular Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D013737:Testis / Q000473:pathology; D014750:Vincristine / Q000627:therapeutic use
D000510:Alpha-Globulins; D005326:Fetal Proteins; D003609:Dactinomycin; D008466:Mechlorethamine; D014750:Vincristine; D003520:Cyclophosphamide; D008727:Methotrexate